Literature DB >> 21336717

Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Hui Du1, Haiyi Liu1, Jun Zhao1, Yuanyuan Wu1, Xun Gong1, Qiong Zhou1, Jingjing Xu1, Yuqi Li1, Xinwei Shi1, Fuyuan Qiao2.   

Abstract

The mechanism of injury on the human glomerular endothelial cells (ciGENC) induced by preeclampsia serum was investigated. Concentration of maternal serum sFlt-1 protein was detected by ELISA. Fluorescently-labeled bovine serum albumin infiltrating through lower chamber of Transwell was measured by multifunction microplate reader. Morphologic change of ciGENC was observed under inverted phase contrast microscope. The concentration of sflt-1 in preeclampsia groups was significantly increased as compared with control group (P<0.01). Permeability in preeclampsia groups was significantly increased as compared with control group (P<0.01). By contrast with severe preeclampsia group, the permeability of ciGENC monolayer in mild preeclampsia group was decreased significantly (P<0.05). Intervention of exogenous VEGF significantly decreased permeability of ciGENC in preeclampsia groups. It was concluded that sFlt-1 increased ciGENC permeability by damaging integrity of endothelial barrier function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21336717     DOI: 10.1007/s11596-011-0143-7

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  25 in total

1.  Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events?

Authors:  Alfredo M Germain; Mary Carmen Romanik; Irene Guerra; Sandra Solari; María Soledad Reyes; Richard J Johnson; Karen Price; S Ananth Karumanchi; Gloria Valdés
Journal:  Hypertension       Date:  2006-11-20       Impact factor: 10.190

Review 2.  The role of podocytes in proteinuria.

Authors:  Katsuhiko Asanuma; Etsuko Yanagida-Asanuma; Miyuki Takagi; Fumiko Kodama; Yasuhiko Tomino
Journal:  Nephrology (Carlton)       Date:  2007-12       Impact factor: 2.506

Review 3.  Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia.

Authors:  Babbette D LaMarca; Jeffery Gilbert; Joey P Granger
Journal:  Hypertension       Date:  2008-02-07       Impact factor: 10.190

4.  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.

Authors:  Duk-Hee Kang; Jeremy Hughes; Marilda Mazzali; George F Schreiner; Richard J Johnson
Journal:  J Am Soc Nephrol       Date:  2001-07       Impact factor: 10.121

5.  In preeclampsia, the circulating factors capable of altering in vitro endothelial function precede clinical disease.

Authors:  Jenny Myers; Gary Mires; Maureen Macleod; Philip Baker
Journal:  Hypertension       Date:  2005-01-03       Impact factor: 10.190

6.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Preeclamptic sera induce nephrin shedding from podocytes through endothelin-1 release by endothelial glomerular cells.

Authors:  Federica Collino; Benedetta Bussolati; Elisa Gerbaudo; Luca Marozio; Simona Pelissetto; Chiara Benedetto; Giovanni Camussi
Journal:  Am J Physiol Renal Physiol       Date:  2008-02-20

Review 8.  Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.

Authors:  Duk-Hee Kang; Richard J Johnson
Journal:  Curr Opin Nephrol Hypertens       Date:  2003-01       Impact factor: 2.894

9.  Circulating leptin and angiogenic factors in preeclampsia patients.

Authors:  Hideki Nakatsukasa; Hisashi Masuyama; Norio Takamoto; Yuji Hiramatsu
Journal:  Endocr J       Date:  2008-05-20       Impact factor: 2.349

10.  Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences.

Authors:  Vassilis Tsatsaris; Frederic Goffin; Carine Munaut; Jean-François Brichant; Marie-Rose Pignon; Agnes Noel; Jean-Pierre Schaaps; Dominique Cabrol; Francis Frankenne; Jean-Michel Foidart
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  1 in total

1.  Upregulation of sFlt-1 by trophoblasts induces the barrier dysfunction of glomerular endothelial cells.

Authors:  Jun Zhao; Haiyi Liu; Hui Du; Fuyuan Qiao; Yvqi Li; Xinwei Shi; Xun Gong; Yuanyuan Wu; Qiong Zhou; Jingjing Xu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.